BOSTON (MedPage Today) -- Availability of direct antiviral drugs for hepatitis C virus (HCV) infection moved another step closer to realization, with favorable results reported here for telaprevir in two Phase II studies.
AASLD: High SVR Rates Seen with Telaprevir for Hepatitis C (CME/...Courtesy MedPage Today Infectious Disease Fri, 11/06/2009 - 15:10
BOSTON (MedPage Today) -- Availability of direct antiviral drugs for hepatitis C virus (HCV) infection moved another step closer to realization, with favorable results reported here for telaprevir in two Phase II studies. More related itemsASN: HCV Infection Virtually Untreated in Dialysis...
Drug Ups Response Rate in Refractory Hepatitis C...
DDW: Study Backs HCV Screens for All Boomers (CME/CE)
|
Popular by tags WeekMonth |
Post new comment